Literature DB >> 21315333

Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits.

Jung Ryeol Lee1, Seok Hyun Kim, Byung Chul Jee, Chang Suk Suh, Ki Chul Kim, Shin Yong Moon.   

Abstract

This study was performed to compare antimüllerian hormone (AMH) levels measured by two commercially available AMH measuring kits currently available, and to evaluate the AMH levels as predictor of controlled ovarian hyperstimulation (COH) outcome using the two different kits. The two assays for AMH measurement provide similar results, and serum AMH levels measured by the two kits both could be used as COH outcome predictors with similar reference values.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21315333     DOI： 10.1016/j.fertnstert.2011.01.126

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  6 in total

1.  Impact of breast cancer on anti-mullerian hormone levels in young women.

Authors:  H I Su; S W Flatt; L Natarajan; A DeMichele; A Z Steiner
Journal:  Breast Cancer Res Treat       Date:  2012-12-09       Impact factor: 4.872

2.  Comparability of antimüllerian hormone levels among commercially available immunoassays.

Authors:  H Irene Su; Mary D Sammel; Michael V Homer; Kim Bui; Carolyn Haunschild; Frank Z Stanczyk
Journal:  Fertil Steril       Date:  2014-04-14       Impact factor: 7.329

3.  Correlation between three assay systems for anti-Müllerian hormone (AMH) determination.

Authors:  Hang Wun Raymond Li; Ernest Hung Yu Ng; Benancy Po Chau Wong; Richard A Anderson; Pak Chung Ho; William Shu Biu Yeung
Journal:  J Assist Reprod Genet       Date:  2012-11-02       Impact factor: 3.412

4.  Reference intervals of anti-Müllerian hormone in Korean women.

Authors:  Rihwa Choi; Sang Gon Lee; Eun Hee Lee
Journal:  J Clin Lab Anal       Date:  2022-07-19       Impact factor: 3.124

Review 5.  Challenges in Measuring AMH in the Clinical Setting.

Authors:  Hang Wun Raymond Li; David Mark Robertson; Chris Burns; William Leigh Ledger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

6.  Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome.

Authors:  Jae Eun Lee; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh; Ki Chul Kim; Won Don Lee; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2012-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.